AI assistant
SANGAMO THERAPEUTICS, INC — Director's Dealing 2018
Jan 5, 2018
33659_dirs_2018-01-04_c3e6ce6c-b2b1-46e2-8ef3-7cd8935b041b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SANGAMO THERAPEUTICS, INC (SGMO)
CIK: 0001001233
Period of Report: 2018-01-02
Reporting Person: Herberts Curt A. III (Sr.VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-02 | Common Stock | M | 782 | $9.41 | Acquired | 13015 | Direct |
| 2018-01-02 | Common Stock | M | 209 | $8.87 | Acquired | 13224 | Direct |
| 2018-01-02 | Common Stock | S | 6974 | $16.35 | Disposed | 6250 | Direct |
| 2018-01-03 | Common Stock | M | 8026 | $12.12 | Acquired | 14276 | Direct |
| 2018-01-03 | Common Stock | S | 8026 | $18.05 | Disposed | 6250 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-02 | Stock Option (Right to Buy) | $9.41 | M | 782 | Disposed | 2025-12-07 | Common Stock (782) | Direct |
| 2018-01-02 | Stock Option (Right to Buy) | $8.87 | M | 209 | Disposed | 2025-07-26 | Common Stock (209) | Direct |
| 2018-01-03 | Stock Option (Right to Buy) | $12.12 | M | 8026 | Disposed | 2023-12-11 | Common Stock (8026) | Direct |
Footnotes
F1: All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
F2: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the December 8, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
F3: One-quarter (1/4) of the option shares vested and became exercisable upon completion of one (1) year of service by the Reporting Person measured from the July 27, 2015 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
F4: Fully vested and exercisable.